Navigation Links
EU Adopts New Diagnostics and Medical Device Regulations, USDM Life Sciences Helps Organizations Comply
Date:4/8/2017

USDM Life Sciences, the leading risk management, technological innovation and business process optimization firm for the life sciences and healthcare industries, is already working with medical device manufacturers to comply with the two new European Union medical device regulations.

On April 5, 2017, the In vitro Diagnostic Medical Devices Regulation (IVDR) and Medical Devices Regulation (MDR) were approved by the European Parliament.

USDM has been actively following these regulations and is already working with their medical device clients to help plan their regulatory understanding, strategy and implementation. Jay Crowley and Grant Hodgkins oversee medical device compliance services and solutions for USDM.

Crowley is the author of the US FDA UDI Final Rule and is Vice President of UDI Services and Solutions at USDM. Hodgkins was a senior manager at Novartis and Alcon for Master Data Management (MDM) and Product Identification and is the Vice President of Commercial Services and Solutions at USDM.

“These directives are the most recent steps in the global rollout of new medical device identification regulations. These steps, along with the US FDA UDI Final Rule and other similar regulations from other countries that are expected soon will continue the worldwide initiative to improve medical device identification, product quality and patient safety,” said Crowley. “We look forward to helping the industry with this important initiative.”

For medical device manufacturers selling devices in the EU, the timeline for compliance has begun – three years for MDR and 5 years for IVDR. USDM will continue to support Medical Device companies through its Knowledge Webinars, White Papers and participation in the European UDI Conference in Brussels May 16-18. and the US UDI Conference in Baltimore June 7-8. USDM is also presenting a webinar, New EU Diagnostics and Medical Device Regulations on April 20th.

About USDM Life Sciences
USDM Life Sciences is a global life science and healthcare services company, providing strategy and compliant technology solutions to regulated industries. If you work in Life Sciences or Healthcare, partnering with USDM Life Sciences makes it easy to accelerate innovation and maximize productivity. USDM Life Sciences only focuses on regulated industries and has built trusted partnerships with the most innovative technology companies in the world, and boast a staff of industry leading experts in the areas of technology and compliance.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14223667.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Vitatech Adopts Cinnamon through the American Botanical Councils Adopt-an-Herb Program
2. Multivitamin Direct Adopts InstantGMP-Lite as Their Electronic Batch Record Software
3. Oklahoma State Medicaid Adopts Drug Price Benchmark, PAC
4. InspireMD Secures Financing to Accelerate Advancements in Product Development and Adopts a One Year Stockholder Rights Plan
5. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
6. Ixoreal Biomed "Adopts" Ashwagandha through the American Botanical Council
7. FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R
8. Neogen CEO adopts 10b5-1 Trading Plan
9. Kineticos Adopts Practice Area Structure, Expands Consulting Service Areas
10. Texas Fertility Center Adopts Next-gen DNA Sequencing, Inclusive Screening at all of Its San Antonio and Austin Fertility Clinics
11. Teawolf "Adopts" Guayusa under Agreement with American Botanical Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 2017 , ... Stratevi, a boutique firm that partners with healthcare companies to ... an office in downtown Boston at 745 Atlantic Ave. , “We are seeing ... evidence on the value they provide, not just to patients, but also payers. Having ...
(Date:5/22/2017)... , ... May 22, 2017 , ... ... that it is exhibiting in booth B2 at the Association for Pathology ... 22-25. , In addition to demonstrating its Cancer Diagnostic Cockpit and Consultation ...
(Date:5/21/2017)... ... May 20, 2017 , ... CNSDose is ... trial and error process by finding the right antidepressant faster. CNSDose speeds ... doctor-patient relationship through a personalized approach to treatment. , A peer-reviewed ...
(Date:5/19/2017)... ... May 19, 2017 , ... The University City Science ... technologies ripe for commercialization, and who are affiliated with the 21 partner academic ... proposals. QED, now in its tenth round, is the first multi-institutional proof-of-concept program ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
Breaking Biology News(10 mins):